DRMA
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 48.33K | New | $58,483 | 0.0% | New | 1 | SEC ↗ ×2 |
| 2 | UBS Group AG | 36.91K | +2884.0% | $43,105 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | Citigroup Inc | 1 | New | $1 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Geode Capital Management | $58,483 | 0.0% |
| Citigroup Inc | $1 | 0.0% |
Exited
| Bank Of America Corp /De/ | $8,020 | was 0.0% |
| Barclays Plc | $5,573 | was 0.0% |
| JPMorgan Chase | $1,615 | was 0.0% |
| Susquehanna International… | $253 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 13.30K shares, $14,540 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
9.0% of class · View original SEC filing ↗